Sam S. Yoon / Columbia University, USA | ||
February 10 (Fri) | Symposium 1: Clinical Implications of the Intrinsic Molecular Subtypes and NGS Panel of Solid Tumors Gastric cancer |
|
February 10 (Fri) | Symposium 3: Rare Tumors Sarcoma and GIST |
Sandra L. Wong / President of SSO, Dartmouth-Hitchcock Medical Center, USA | ||
February 10 (Fri) | State of the Art Lecture I Measuring patient reported outcomes in cancer patients |
|
February 11 (Sat) | International Surgical Oncologist Liaison Future perspectives of SSO in post COVID-19 |
Isabel Teresa Rubio / President of ESSO, Clinica Universidad de Navarra, Spain | ||
February 11 (Sat) | International Surgical Oncologist Liaison Future perspectives of ESSO in post COVID-19 |
|
February 11 (Sat) | State of the Art Lecture II De-escalation in axillary surgery in breast cancer |
Yuichiro Doki / Chairman of JSCO, Osaka University, Japan | ||
February 11 (Sat) | International Surgical Oncologist Liaison Future perspectives of JSCO in post COVID-19 |
Jun Watanabe / Yokohama City University Medical Center, Japan | ||
February 10 (Fri) | Symposium 2: Updates of MIS: Focused on Reduced Port Laparoscopic Robot Surgery Single-incision laparoscopic surgery for colorectal cancer: Outcomes of multicenter randomized controlled study |
Cheng-Ming Peng / Chung Shan Medical University Hospital, Taiwan | ||
February 10 (Fri) | Symposium 2: Updates of MIS: Focused on Reduced Port Laparoscopic Robot Surgery Reduced port laparoscopic or robot pancreatectomy for pancreas cancer |
Ava Kwong / University of Hong Kong, Hong Kong, China | ||
February 10 (Fri) | Symposium 7: Screening & Management of Hereditary Cancers Hereditary breast cancer and risk-reducing surgery |
Yukinori Kurokawa / Osaka University, Japan | ||
February 10 (Fri) | Symposium 8: Recent Update about Treatment of Oligometastasis Surgery for oligometastasis from gastric cancer |
Carmela Caballero / EYSAC Chair, Breast International Group, Belgium | ||
February 11 (Sat) | Special Session 2: Next Generation Session Role of young surgical oncologist in a rapidly evolving cancer research landscape |
Chang-ming Huang / Fujian Medical University, China | ||
February 11 (Sat) | Symposium 10: Robotic Surgery in Solid Tumor Current status and new approaches of robotic surgery for gastric cancer |
Jimmy So / National University of Singapore, Singapore | ||
February 11 (Sat) | Symposium 11: Treatment of Peritoneal Metastasis [KSPSM Joint Session] Cytoreductive surgery for peritoneal metastatic cancer: current evidence and consensus |
Kazuhiro Yoshida / Gifu University, Japan | ||
February 11 (Sat) | Symposium 12: Oncologic Benefit of Conversion Surgery following Palliative Chemotherapy for Initially Unresectable Cancer Current evidence of conversion surgery for stage IV gastric cancer |
Thilo Hackert / Heidelberg University Hospital, Germany | ||
February 11 (Sat) | Symposium 12: Oncologic Benefit of Conversion Surgery following Palliative Chemotherapy for Initially Unresectable Cancer The prognostic role of conversion surgery in locally advanced pancreatic cancer |
G.V. Rao / AIG Hospitals & Asian Institute of Gastroenterology, India | ||
February 11 (Sat) | KSSO-ISFGS AP Chapter Joint Symposium 1: Overviews of Fluorescence Guided Surgery in AP Region Expected roles of fluorescence guided surgery in India |
Takeaki Ishizawa / Osaka Metropolitan University, Japan | ||
February 11 (Sat) | Luncheon Seminar (Sponsored by Stryker) Expanding application of intraoperative fluorescence imaging in Asia-Pacific regions |
Catherine Teh / Makati Medical Center, Philippines | ||
February 11 (Sat) | KSSO-ISFGS AP Chapter Joint Symposium 1: Overviews of Fluorescence Guided Surgery in AP Region Possible RCT focusing on decrease in BDI by fluorescence cholangiography |
Gavin Wright / St Vincent's Hospital Melbourne, Australia | ||
February 11 (Sat) | KSSO-ISFGS AP Chapter Joint Symposium 1: Overviews of Fluorescence Guided Surgery in AP Region Lung segmentation: basic techniques and future prospects in Oceanian countries |
Yasuteru Urano / University of Tokyo, Japan | ||
February 11 (Sat) | KSSO-ISFGS AP Chapter Joint Symposium 1: Overviews of Fluorescence Guided Surgery in AP Region Development of enzyme-activatable fluorophores for cancer-specific imaging |
Xiaoying Wang / Zhongshan Hospital, Fudan University, China | ||
February 11 (Sat) | KSSO-ISFGS AP Chapter Joint Symposium 2: Clinical Applications of Fluorescence Guided Surgery Has hepatic segmentation by fluorescence imaging changed clinical practices in China? |
Rawisak Chanwat / National Cancer Institute, Thailand | ||
February 11 (Sat) | KSSO-ISFGS AP Chapter Joint Symposium 2: Clinical Applications of Fluorescence Guided Surgery Applications of fluorescence imaging in HBP surgery |
Ian Wong / Queen Mary Hospital, Hong Kong SAR, China | ||
February 11 (Sat) | KSSO-ISFGS AP Chapter Joint Symposium 2: Clinical Applications of Fluorescence Guided Surgery Applications of fluorescence imaging in upper GI surgery |
Ian Tan / National University Health System, Singapore | ||
February 11 (Sat) | KSSO-ISFGS AP Chapter Joint Symposium 2: Clinical Applications of Fluorescence Guided Surgery Perfusion assessment in colorectal surgery |
Po-Chu Lee / National Taiwan University Hospital, Taiwan | ||
February 11 (Sat) | KSSO-ISFGS AP Chapter Joint Symposium 2: Clinical Applications of Fluorescence Guided Surgery ICG fluorescence imaging in proximal gastrectomy |